chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Soft tissue swelling
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 2/27/2023 Discharge Date: Mar 23, 2023 PRESENTING PROBLEM: Hypomagnesemia Debility  Alcohol abuse Weakness COVID-19   HOSPITAL COURSE: 72M with past medical history significant for alcohol use disorder, presented with overall body pain, generalized weakness and fall. He has been seen 4 x in the E.D. in the past few weeks mostly for etoh. He was planning to go to a rehab but sent to the E.D. for medical clearance. He was unable to ambulate in the E.D. so admission was requested for PT / OT and potentially SAR .He had a CT scan head showing mild soft tissue swelling on the right frontal scalp no intracranial hemorrhage midline shift or mass effect.  Left knee x-ray showing sclerotic changes in the proximal tibia concerning for metastatic disease.  PSA within normal limits.   Due to the patient's abdominal pain and CT abdomen and pelvis done showed fatty liver and questionable cirrhosis.    He was given multivitamin thiamine folic acid and Ativan p.r.n. for alcohol withdrawal.   PT and OT recommended skilled nursing facility, neurology patient was awaiting placement he spiked fevers greater than and 39 C. A chest x-ray was negative for any acute processes..  Patient was initiated on vancomycin and cefepime. Work up was positive for COVID on 3/10/23. He was titrated off antibiotics. He developed AKI 2/2 uncontrolled fever and this resolved with IVF as well as fever suppression with tylenol. He developed TME and this improved with fever suppression and correction of AKI. Blood cultures were negative. He remained on room air during his acute COVID episode.    He completed 10 days of COVID isolation on 03/21 and was discharged In stable condition.
Age: 76.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Malaise, Pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: I did not have an adverse reaction to the vaccine. I started not feeling well on 02/14/2023 with a fever and body aches. I tested positive for COVID-19 on 02/14/2023.  I contacted my doctor and got a prescription for Paxlovid. I tolerated the medication without any complications. As of today, I do not have any lingering symptoms of COVID-19.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Goitre, Pulmonary embolism
Clinical narrative: PULMONARY EMBOLISM, UNSPECIFIED. 1/16/2021 THYROID GOITER
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after2 vaccines Pfizer 4/17/21 Lot# FA6780;  Pfizer 8/9/21 Lot# FC3180
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine was administered 4 days after beyond use date.
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acupuncture, Decreased appetite, Diarrhoea, Fatigue, Headache
Clinical narrative: 10/4/2022 I had a terrible headache that took three days to go away. I had acupunctured the day before. I had diarrhea, vomiting and I was severely fatigued. It took 72 to 96 hours to go get better. I had very little appetite for 10 days. I had multiple Covid tests that were negative (no dates).
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test negative, Vomiting
Clinical narrative: 10/4/2022 I had a terrible headache that took three days to go away. I had acupunctured the day before. I had diarrhea, vomiting and I was severely fatigued. It took 72 to 96 hours to go get better. I had very little appetite for 10 days. I had multiple Covid tests that were negative (no dates).
Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: Asthma, COVID-19, Chest pain, Condition aggravated, Cough
Clinical narrative: I had sore throat, headache and feverish. I waited the next day because I did test positive on a home test. It was a call, I eventually got Paxlovid. I had muscle aches, heart burn, shortness of breath and a cough. My asthma did flare up and I had chest pain. I had to take a second course of Paxlovid, the symptoms started to get worse after I finished the first round of Paxlovid, it got better after 24hrs of the Paxlovid to kick in. After the first round, within 12 hours I was sick again.     I still have some cough and asthma. I am now taking higher doses of my asthma medication and still having issues with heartburn and headaches. The headaches took about two weeks to resolve.
Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dyspepsia, Dyspnoea, Headache, Malaise, Myalgia
Clinical narrative: I had sore throat, headache and feverish. I waited the next day because I did test positive on a home test. It was a call, I eventually got Paxlovid. I had muscle aches, heart burn, shortness of breath and a cough. My asthma did flare up and I had chest pain. I had to take a second course of Paxlovid, the symptoms started to get worse after I finished the first round of Paxlovid, it got better after 24hrs of the Paxlovid to kick in. After the first round, within 12 hours I was sick again.     I still have some cough and asthma. I am now taking higher doses of my asthma medication and still having issues with heartburn and headaches. The headaches took about two weeks to resolve.
Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: Oropharyngeal pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: I had sore throat, headache and feverish. I waited the next day because I did test positive on a home test. It was a call, I eventually got Paxlovid. I had muscle aches, heart burn, shortness of breath and a cough. My asthma did flare up and I had chest pain. I had to take a second course of Paxlovid, the symptoms started to get worse after I finished the first round of Paxlovid, it got better after 24hrs of the Paxlovid to kick in. After the first round, within 12 hours I was sick again.     I still have some cough and asthma. I am now taking higher doses of my asthma medication and still having issues with heartburn and headaches. The headaches took about two weeks to resolve.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Moderna 1/23/21 Lot# 029L20A;  Moderna 2/20/21 Lot# 023M20A;  Moderna 10/19/21 Lo# 076C21A;
Age: 56.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Decreased appetite, Dyspnoea, Injection site swelling, Nasal congestion
Clinical narrative: The day after I received dose 4 in October 2022, I experienced swelling at the injection sight and nausea that lasted about 2 weeks. Also, I tested positive for COVID-19, April 7, 2023. I have experienced fever, runny nose, shortness of breath, nasal congestion, loss of appetite. I began taking PAXLOVID and the side effects gave me diarrhea and muscle cramps. As of today, I still have diarrhea, runny nose, coughing, fever and headache.
Age: 56.0
Sex: M
Vaccine: COVID19-2
Symptoms: Nausea, Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: The day after I received dose 4 in October 2022, I experienced swelling at the injection sight and nausea that lasted about 2 weeks. Also, I tested positive for COVID-19, April 7, 2023. I have experienced fever, runny nose, shortness of breath, nasal congestion, loss of appetite. I began taking PAXLOVID and the side effects gave me diarrhea and muscle cramps. As of today, I still have diarrhea, runny nose, coughing, fever and headache.
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Anticoagulant therapy, Atrial fibrillation, Atrial flutter, COVID-19, Cardioversion
Clinical narrative: Discharge Provider: MD  Primary Care Provider: MD Admission Date: 3/8/2023 Discharge Date: Mar 26, 2023 PRESENTING PROBLEM: Severe sepsis (HCC)  Septic shock (HCC)  Sepsis (HCC) SBO (small bowel obstruction) (HCC)   HOSPITAL COURSE: 72 year old male with past medical history quadriplegic, bilateral AKA, neurogenic bladder, seizure, PVD, HTN presented from a nursing facility with lethargy, hypoxia and shock. He was found to be Covid-19 positive. He as placed on bipap then HFNC and improved on NC.  He then developed septic shock due to urinary tract infection, possible superimposed bacterial and aspiration pneumonia.  He was treated with multiple IV antibiotics including meropenem, vancomycin, cefepime and Zosyn with improvement.  While hospitalized he developed a small-bowel obstruction.  General surgery evaluated the patient and he underwent exploratory laparotomy with lysis of adhesion and small-bowel resection on 03/16.  Repeat imaging showed an ileus.  The patient had an NG tube but ultimately this was removed and the patient diet was slowly advanced.  He required TPN while NPO due to small-bowel obstruction.  He received Decadron for COVID with slow improvement in his respiratory status.  He was weaned to nasal cannula.  Also while hospitalized he developed atrial fibrillation and flutter.  He was treated with amiodarone and converted to normal sinus rhythm.  He was started on IV heparin drip with plan to transition to another facility on DC.  Ultimately the patient was discharged in stable and improved condition on 03/26/2023
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Condition aggravated, Gastrointestinal tube removal, Hypoxia, Ileus, Imaging procedure abnormal
Clinical narrative: Discharge Provider: MD  Primary Care Provider: MD Admission Date: 3/8/2023 Discharge Date: Mar 26, 2023 PRESENTING PROBLEM: Severe sepsis (HCC)  Septic shock (HCC)  Sepsis (HCC) SBO (small bowel obstruction) (HCC)   HOSPITAL COURSE: 72 year old male with past medical history quadriplegic, bilateral AKA, neurogenic bladder, seizure, PVD, HTN presented from a nursing facility with lethargy, hypoxia and shock. He was found to be Covid-19 positive. He as placed on bipap then HFNC and improved on NC.  He then developed septic shock due to urinary tract infection, possible superimposed bacterial and aspiration pneumonia.  He was treated with multiple IV antibiotics including meropenem, vancomycin, cefepime and Zosyn with improvement.  While hospitalized he developed a small-bowel obstruction.  General surgery evaluated the patient and he underwent exploratory laparotomy with lysis of adhesion and small-bowel resection on 03/16.  Repeat imaging showed an ileus.  The patient had an NG tube but ultimately this was removed and the patient diet was slowly advanced.  He required TPN while NPO due to small-bowel obstruction.  He received Decadron for COVID with slow improvement in his respiratory status.  He was weaned to nasal cannula.  Also while hospitalized he developed atrial fibrillation and flutter.  He was treated with amiodarone and converted to normal sinus rhythm.  He was started on IV heparin drip with plan to transition to another facility on DC.  Ultimately the patient was discharged in stable and improved condition on 03/26/2023
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Intestinal adhesion lysis, Laparotomy, Lethargy, Parenteral nutrition, Positive airway pressure therapy
Clinical narrative: Discharge Provider: MD  Primary Care Provider: MD Admission Date: 3/8/2023 Discharge Date: Mar 26, 2023 PRESENTING PROBLEM: Severe sepsis (HCC)  Septic shock (HCC)  Sepsis (HCC) SBO (small bowel obstruction) (HCC)   HOSPITAL COURSE: 72 year old male with past medical history quadriplegic, bilateral AKA, neurogenic bladder, seizure, PVD, HTN presented from a nursing facility with lethargy, hypoxia and shock. He was found to be Covid-19 positive. He as placed on bipap then HFNC and improved on NC.  He then developed septic shock due to urinary tract infection, possible superimposed bacterial and aspiration pneumonia.  He was treated with multiple IV antibiotics including meropenem, vancomycin, cefepime and Zosyn with improvement.  While hospitalized he developed a small-bowel obstruction.  General surgery evaluated the patient and he underwent exploratory laparotomy with lysis of adhesion and small-bowel resection on 03/16.  Repeat imaging showed an ileus.  The patient had an NG tube but ultimately this was removed and the patient diet was slowly advanced.  He required TPN while NPO due to small-bowel obstruction.  He received Decadron for COVID with slow improvement in his respiratory status.  He was weaned to nasal cannula.  Also while hospitalized he developed atrial fibrillation and flutter.  He was treated with amiodarone and converted to normal sinus rhythm.  He was started on IV heparin drip with plan to transition to another facility on DC.  Ultimately the patient was discharged in stable and improved condition on 03/26/2023
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Respiratory disorder, SARS-CoV-2 test positive, Sepsis, Septic shock, Shock
Clinical narrative: Discharge Provider: MD  Primary Care Provider: MD Admission Date: 3/8/2023 Discharge Date: Mar 26, 2023 PRESENTING PROBLEM: Severe sepsis (HCC)  Septic shock (HCC)  Sepsis (HCC) SBO (small bowel obstruction) (HCC)   HOSPITAL COURSE: 72 year old male with past medical history quadriplegic, bilateral AKA, neurogenic bladder, seizure, PVD, HTN presented from a nursing facility with lethargy, hypoxia and shock. He was found to be Covid-19 positive. He as placed on bipap then HFNC and improved on NC.  He then developed septic shock due to urinary tract infection, possible superimposed bacterial and aspiration pneumonia.  He was treated with multiple IV antibiotics including meropenem, vancomycin, cefepime and Zosyn with improvement.  While hospitalized he developed a small-bowel obstruction.  General surgery evaluated the patient and he underwent exploratory laparotomy with lysis of adhesion and small-bowel resection on 03/16.  Repeat imaging showed an ileus.  The patient had an NG tube but ultimately this was removed and the patient diet was slowly advanced.  He required TPN while NPO due to small-bowel obstruction.  He received Decadron for COVID with slow improvement in his respiratory status.  He was weaned to nasal cannula.  Also while hospitalized he developed atrial fibrillation and flutter.  He was treated with amiodarone and converted to normal sinus rhythm.  He was started on IV heparin drip with plan to transition to another facility on DC.  Ultimately the patient was discharged in stable and improved condition on 03/26/2023
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Sinus rhythm, Small intestinal obstruction, Small intestinal resection, Urinary tract infection
Clinical narrative: Discharge Provider: MD  Primary Care Provider: MD Admission Date: 3/8/2023 Discharge Date: Mar 26, 2023 PRESENTING PROBLEM: Severe sepsis (HCC)  Septic shock (HCC)  Sepsis (HCC) SBO (small bowel obstruction) (HCC)   HOSPITAL COURSE: 72 year old male with past medical history quadriplegic, bilateral AKA, neurogenic bladder, seizure, PVD, HTN presented from a nursing facility with lethargy, hypoxia and shock. He was found to be Covid-19 positive. He as placed on bipap then HFNC and improved on NC.  He then developed septic shock due to urinary tract infection, possible superimposed bacterial and aspiration pneumonia.  He was treated with multiple IV antibiotics including meropenem, vancomycin, cefepime and Zosyn with improvement.  While hospitalized he developed a small-bowel obstruction.  General surgery evaluated the patient and he underwent exploratory laparotomy with lysis of adhesion and small-bowel resection on 03/16.  Repeat imaging showed an ileus.  The patient had an NG tube but ultimately this was removed and the patient diet was slowly advanced.  He required TPN while NPO due to small-bowel obstruction.  He received Decadron for COVID with slow improvement in his respiratory status.  He was weaned to nasal cannula.  Also while hospitalized he developed atrial fibrillation and flutter.  He was treated with amiodarone and converted to normal sinus rhythm.  He was started on IV heparin drip with plan to transition to another facility on DC.  Ultimately the patient was discharged in stable and improved condition on 03/26/2023
Age: 22.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient was given Moderna Bivalent instead of the Moderna Monovalent as the 2nd dose of the primary series.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 4 vaccines Pfizer 1/20/21  Lot# El3249;  Pfizer 2/7/21 Lot# EL9265;  Pfizer 9/26/21 Lot# FF8841 ; Pfizer 4/11/22 Lot# FJ9943;
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Aortic valve stenosis, Atrial fibrillation, Cardiogenic shock, Coronary artery disease
Clinical narrative: ACUTE ST ELEVATION MI, ANTERIOR WALL 7/12/2021 ATRIAL FIBRILLATION, UNSPECIFIED CARDIOGENIC SHOCK 7/12/2021 ATRIAL FIBRILLATION, UNSPECIFIED ACUTE ST ELEVATION MI, ANTERIOR WALL 7/12/2021 ATRIAL FIBRILLATION, UNSPECIFIED CARDIOGENIC SHOCK 7/12/2021 ATRIAL FIBRILLATION, UNSPECIFIED ACUTE ST ELEVATION MI, ANTERIOR WALL 7/12/2021 AORTIC VALVE STENOSIS    CARDIOGENIC SHOCK CARDIOGENIC SHOCK 7/12/2021 AORTIC VALVE STENOSIS    CARDIOGENIC SHOCK ACUTE ST ELEVATION MI, ANTERIOR WALL 7/12/2021 AORTIC VALVE STENOSIS CARDIOGENIC SHOCK 7/12/2021 AORTIC VALVE STENOSIS ACUTE ST ELEVATION MI, ANTERIOR WALL 7/12/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA CARDIOGENIC SHOCK 7/12/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA ACUTE ST ELEVATION MI, ANTERIOR WALL 7/12/2021 ACUTE UTI CARDIOGENIC SHOCK 7/12/2021 ACUTE UTI
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: ACUTE ST ELEVATION MI, ANTERIOR WALL 7/12/2021 ATRIAL FIBRILLATION, UNSPECIFIED CARDIOGENIC SHOCK 7/12/2021 ATRIAL FIBRILLATION, UNSPECIFIED ACUTE ST ELEVATION MI, ANTERIOR WALL 7/12/2021 ATRIAL FIBRILLATION, UNSPECIFIED CARDIOGENIC SHOCK 7/12/2021 ATRIAL FIBRILLATION, UNSPECIFIED ACUTE ST ELEVATION MI, ANTERIOR WALL 7/12/2021 AORTIC VALVE STENOSIS    CARDIOGENIC SHOCK CARDIOGENIC SHOCK 7/12/2021 AORTIC VALVE STENOSIS    CARDIOGENIC SHOCK ACUTE ST ELEVATION MI, ANTERIOR WALL 7/12/2021 AORTIC VALVE STENOSIS CARDIOGENIC SHOCK 7/12/2021 AORTIC VALVE STENOSIS ACUTE ST ELEVATION MI, ANTERIOR WALL 7/12/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA CARDIOGENIC SHOCK 7/12/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA ACUTE ST ELEVATION MI, ANTERIOR WALL 7/12/2021 ACUTE UTI CARDIOGENIC SHOCK 7/12/2021 ACUTE UTI
Age: 0.75
Sex: M
Vaccine: DTAPIPVHIB, FLU4, HIBV, PNC13
Symptoms: Extra dose administered
Clinical narrative: Patient was accidently given two different HIB vaccines.
Age: 29.0
Sex: M
Vaccine: PNC20
Symptoms: Injected limb mobility decreased, Injection site pain, Pain, Pain in extremity
Clinical narrative: First two days after injection arm was swollen and it hurt to raise arm.  Could not lift arm above head.  Pain subsided and mobility increased over the next 4 weeks, but was still very painful to put pressure on injection site and move arm in certain ways.   Called nurse and was recommended to take ibuprofen, and use ice on area.  3 weeks later little to no improvement was noticed.  Called nurse again and was recommended to continue ibuprofen and ice and rotate in heat and also to massage the area.  A few days after this with little improvement I schedule a video doctor's apt (the quickest apt I could get) for April 13.  By the time of the doctors apt the pain was localized to about a dime sized area.  Painful and tender when pressure is applied.  Painful to move arm in certain ways such as reaching over head and touching left shoulder and putting right hand on hip and pushing elbow forward.  Photos were sent to doctor to show where the pain was occurring and where the injection site was.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Moderna 3/15/21 Lot# 044A21A;  Moderna 3/15/21 Lot#030A21A;  MOderna 4/14/21 Lot# 043B21A
Age: 3.0
Sex: F
Vaccine: FLU4
Symptoms: Abdominal discomfort, Retching, Vomiting
Clinical narrative: After post-vaccine monitoring x approx 15-20 min, left clinic with parent; report of vomiting outside clinic and in car preparing to drive home; returned to clinic for eval & monitored x approx 1 hour 20 minutes further; vital signs & presentation/affect unchanged from baseline calm/cooperative & only c/o stomach upset x approx 10 minutes; noted to dry heave x 2 occasions during monitoring ; no s/s swelling, rash, respiratory distress, crying or distress noted; reported feeling ok after monitoring & discharged in stable/baseline condition w/ mother
Age: 66.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Nasopharyngitis, Respiratory tract congestion, SARS-CoV-2 test negative
Clinical narrative: I got really congested, we knew it was just a cold. I did a home COVID-19 test that came back negative, with all that is going around my doctor prescribed TAMIFLU to help me get over what I was going through. It did help, but I am still congested. It may be allergy related.
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Atrial fibrillation, Electrocardiogram abnormal, Heart rate increased, Scan abnormal
Clinical narrative: I had on 09NOV2022 a AFIB attack and then a second on 16MAR2023. I also went the ER because of a rapid heartbeat in the month of March 2023.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Lung carcinoma cell type unspecified stage 0
Clinical narrative: HYPOXIA 11/5/2021 MALIGNANT NEOPLASM UNS PART UNS BRONCHUS/LUNG
Age: 80.0
Sex: M
Vaccine: COVID19-2
Symptoms: Abdominal pain upper, Blood creatinine, Cholecystectomy, Computerised tomogram pelvis, Electrocardiogram
Clinical narrative: 02/22/2023 I had a horrible stomach ache I went to the ER and they removed my gallbladder the same night. I was admitted for 4 days. I have fully recovered.
Age: 80.0
Sex: M
Vaccine: COVID19-2
Symptoms: Full blood count, Liver function test, Metabolic function test, Troponin
Clinical narrative: 02/22/2023 I had a horrible stomach ache I went to the ER and they removed my gallbladder the same night. I was admitted for 4 days. I have fully recovered.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Pfizer 5/27/21 Lot# EW0186;  Pfizer 6/17/21 Lot# EW0191
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Hypoxia
Clinical narrative: ACUTE RESPIRATORY FAILURE 10/30/2021 NONTRAUMATIC ACUTE KIDNEY INJURY  HYPOXIA 10/30/2021 NONTRAUMATIC ACUTE KIDNEY INJURY  ACUTE RESPIRATORY FAILURE 10/30/2021 ACUTE RENAL FAILURE, UNSPECIFIED  HYPOXIA 10/30/2021 ACUTE RENAL FAILURE, UNSPECIFIED
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines  Pfizer 2/25/21 Lot# EN6202;  Pfizer 3/18/21 Lot# ER2613
Age: 76.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Malaise, Oropharyngeal pain, Pyrexia, Rhinorrhoea
Clinical narrative: I had a runny nose and a slightly sore throat. I also had a low-grade fever. It was very mild but since I was scheduled for an operation the following day, the symptoms became more severe than the previous day. I called my doctor and was prescribed. I began taking the treatment the next day. My symptoms had worsened by this point. I began to feel alright for 3 or 4 days and remained positive until December. I had mild symptoms that had been gone before the test reflected that I was negative for the virus.
Age: 76.0
Sex: M
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I had a runny nose and a slightly sore throat. I also had a low-grade fever. It was very mild but since I was scheduled for an operation the following day, the symptoms became more severe than the previous day. I called my doctor and was prescribed. I began taking the treatment the next day. My symptoms had worsened by this point. I began to feel alright for 3 or 4 days and remained positive until December. I had mild symptoms that had been gone before the test reflected that I was negative for the virus.
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: Sinusitis, Vertigo
Clinical narrative: I was diagnosed with vertigo and sinus infection I was prescribed Meclizine; Zyrtec for the sinus infection
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Adenocarcinoma pancreas, Anticoagulant therapy, Diarrhoea, Hypotension, Pulmonary embolism
Clinical narrative: HYPOTENSION 8/28/2021 LONG TERM ANTICOAGULANT THERAPY  HYPOTENSION 8/28/2021 DIARRHEA  HYPOTENSION 8/28/2021 ACUTE PULMONARY EMBOLISM  HYPOTENSION 8/28/2021 ADENOCARCINOMA, BODY OF PANCREAS  HYPOTENSION 8/28/2021 ACUTE PULMONARY EMBOLISM  HYPOTENSION 8/28/2021 ADENOCARCINOMA, BODY OF PANCREAS
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 4 vaccines Moderna 1/29/21 Lot# 031L20A;  Moderna 2/26/21  Lot# 023M20A;  Moderna 10/25/21 Lot# 012F;  Moderna 5/12/22 Lot# 049L21A
Age: 0.17
Sex: M
Vaccine: DTAP, HIBV
Symptoms: Abnormal behaviour, Crying, Febrile convulsion, Hypersomnia, Injection site reaction
Clinical narrative: Pt received 2 month vaccines today and per mom pt has been acting different since.  Per mom pt has been crying nonstop and if he is not crying he is eating or slepping.  per mom pt has been sleeping more than usual.  per mom pt appt was at 8am this morning  following appt pt has eaten at 1030 3oz and 1250 80ml and feeding while speaking.  per mom pt had episodes where teh R leg was twitching it was short episodes with several twitches pt temp is 99.5 no redness or swelling at site of immunization.  voiding WNL. mom concern is twitching is side effect to vaccines and should be reported and also febrile seizures
Age: 0.17
Sex: M
Vaccine: DTAP, HIBV
Symptoms: Muscle twitching
Clinical narrative: Pt received 2 month vaccines today and per mom pt has been acting different since.  Per mom pt has been crying nonstop and if he is not crying he is eating or slepping.  per mom pt has been sleeping more than usual.  per mom pt appt was at 8am this morning  following appt pt has eaten at 1030 3oz and 1250 80ml and feeding while speaking.  per mom pt had episodes where teh R leg was twitching it was short episodes with several twitches pt temp is 99.5 no redness or swelling at site of immunization.  voiding WNL. mom concern is twitching is side effect to vaccines and should be reported and also febrile seizures
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Pain in extremity, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: My arm was sore for about a day after receiving the vaccine. I tested positive for COVID-19 on 04/10/2023. I felt congested and I had a cough. I contacted my doctor and we talked about Paxlovid, but I declined to take it.  I did not take anything to help with my symptoms. I got plenty of rest, drank a lot of water and self isolated. As of today, I am feeling better.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Aortic arteriosclerosis, Cardiac failure congestive, Hypothyroidism, Neuropathy peripheral
Clinical narrative: G62.9 NEUROPATHY 6/20/2022 ATHEROSCLEROSIS OF AORTA G62.9 NEUROPATHY 6/20/2022 ATHEROSCLEROSIS OF AORTA    CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED G62.9 NEUROPATHY 6/20/2022 HYPOTHYROIDISM
Age: 17.0
Sex: M
Vaccine: MNQ
Symptoms: Wrong product administered
Clinical narrative: Patient was given 0.5 mL meningococcal serogroups A, C, Y &W (MENVO) and was supposed to be given meningococcal serogroup B (MEN B). Patient did not have any adverse reactions.
Age: 68.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Amnesia, Blindness, Dizziness, Fatigue, Impaired work ability
Clinical narrative: blurred vision , fatique , unable to work , dizziness , lost of memory
Age: 68.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Vision blurred
Clinical narrative: blurred vision , fatique , unable to work , dizziness , lost of memory
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, SARS-CoV-2 test positive
Clinical narrative: I had an occasional dry cough for a couple days with no other symptoms. I took a COVID-19 test on 12/30/2022 and it came back positive. I spoke to an on-call doctor who prescribed me PAXLOVID. The PAXLOVID did leave a metallic taste in my mouth but it did help.
Age: 59.0
Sex: M
Vaccine: COVID19-2, FLUX
Symptoms: Asthenia, COVID-19, Fatigue, Oropharyngeal pain, Pyrexia
Clinical narrative: 3/20/23 started with a sore throat in the evening. 3/21 felt bad and tested on an at home COVID-19 test, positive. Televisit with doctor who PAXLOVID on 3/22. This felt like a bad sinus infection with fatigue and weakness. Fever peaking at 102, but that only lasted a couple of days. Fatigue lasted about 11 days.
Age: 59.0
Sex: M
Vaccine: COVID19-2, FLUX
Symptoms: SARS-CoV-2 test positive, Sinus disorder
Clinical narrative: 3/20/23 started with a sore throat in the evening. 3/21 felt bad and tested on an at home COVID-19 test, positive. Televisit with doctor who PAXLOVID on 3/22. This felt like a bad sinus infection with fatigue and weakness. Fever peaking at 102, but that only lasted a couple of days. Fatigue lasted about 11 days.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebellar artery occlusion, Cerebrovascular accident, Deep vein thrombosis, Hyperkalaemia, Ischaemic stroke
Clinical narrative: ACUTE STROKE DUE TO OCCLUSION OF LEFT CEREBELLAR ARTERY 3/31/2021 ACUTE DVT OF RIGHT INTERNAL JUGULAR VEIN  ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 3/31/2021 ACUTE DVT OF RIGHT INTERNAL JUGULAR VEIN  ACUTE STROKE DUE TO OCCLUSION OF LEFT CEREBELLAR ARTERY 3/31/2021 HYPERKALEMIA  ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 3/31/2021 HYPERKALEMIA  ACUTE STROKE DUE TO OCCLUSION OF LEFT CEREBELLAR ARTERY 3/31/2021 ACUTE STROKE DUE TO OCCLUSION OF LEFT CEREBELLAR ARTERY  ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 3/31/2021 ACUTE STROKE DUE TO OCCLUSION OF LEFT CEREBELLAR ARTERY
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Jugular vein thrombosis
Clinical narrative: ACUTE STROKE DUE TO OCCLUSION OF LEFT CEREBELLAR ARTERY 3/31/2021 ACUTE DVT OF RIGHT INTERNAL JUGULAR VEIN  ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 3/31/2021 ACUTE DVT OF RIGHT INTERNAL JUGULAR VEIN  ACUTE STROKE DUE TO OCCLUSION OF LEFT CEREBELLAR ARTERY 3/31/2021 HYPERKALEMIA  ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 3/31/2021 HYPERKALEMIA  ACUTE STROKE DUE TO OCCLUSION OF LEFT CEREBELLAR ARTERY 3/31/2021 ACUTE STROKE DUE TO OCCLUSION OF LEFT CEREBELLAR ARTERY  ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 3/31/2021 ACUTE STROKE DUE TO OCCLUSION OF LEFT CEREBELLAR ARTERY
Age: 55.0
Sex: M
Vaccine: COVID19-2
Symptoms: Blood test, Dizziness, Fatigue, Impaired driving ability, Impaired work ability
Clinical narrative: 2/7/23 ? I had a very sudden attack of fatigue, headache and dizziness to where I could not work anymore. I was unable to drive. I called my doctor?s office, and they had no appointment available, so I went to the Emergency Room.  I had a lot of tests and did not find a cause for my symptoms.  I followed up with my family doctor twice after that within a period of two weeks. I tried two prescriptions which did not help. I had an MRI of my head on 3/11/23 that was normal. I had an appointment with my doctor on 3/30/23. I had bloodwork. I will get the results tomorrow. My symptoms are continuing.
Age: 55.0
Sex: M
Vaccine: COVID19-2
Symptoms: Magnetic resonance imaging head normal
Clinical narrative: 2/7/23 ? I had a very sudden attack of fatigue, headache and dizziness to where I could not work anymore. I was unable to drive. I called my doctor?s office, and they had no appointment available, so I went to the Emergency Room.  I had a lot of tests and did not find a cause for my symptoms.  I followed up with my family doctor twice after that within a period of two weeks. I tried two prescriptions which did not help. I had an MRI of my head on 3/11/23 that was normal. I had an appointment with my doctor on 3/30/23. I had bloodwork. I will get the results tomorrow. My symptoms are continuing.
Age: 15.0
Sex: M
Vaccine: MNQ
Symptoms: Incorrect dose administered, Product preparation issue, Underdose
Clinical narrative: Menveo is a two-part vaccine. It has a powder in one vile that is to be reconstituted with a specific liquid from another vile. It was discovered by our vaccine coordinator that there was half of a dose left unused on three separate occasions. This was discovered in the late fall/early winter 2022. This means that there are three patients of our practice who received incomplete Menveo vaccines and we have not yet identified them. Presumably, the powder was reconstituted in a separate diluent.  We had IT run a report of all patients in a certain window of time who received Menveo at our practice. We compared it with our handwritten logs that clinical staff use to track all vaccines.  Unfortunately, the best we could do was to rule down the list to 8 potential patients. I did submit a separate report about one of these patients a few months ago as that was the first patient potentially identified   We have done lots of reeducation with clinical staff since this time. We have also implemented a protocol that all pediatric vaccines must be double checked by a second clinical staff person before being administered. Our vaccine coordinator is also taking a manual inventory weekly to ensure that should a mistake be made, we are aware of it closer to the date or error. We have also discussed with the medical director that for state supplied vaccines we are going to phase out the use of Menveo (two vial dose) and go back to using a (single vial dose.)  The course of action is to place a call to each of the 7 patients who got Menveo in the suspected time frame and explain that while we are not sure they are under vaccinated, it cannot hurt anything to repeat the Menveo vaccine. That would ensure they are fully vaccinated.  Our medical director and the CDC has advised that a repeat dose is appropriate and should be offered to anyone affected. PCPs have been alerted and agree with the plan for office manager to reach out to patients/guardians
Age: 35.0
Sex: F
Vaccine: COVID19-2
Symptoms: Asthenopia, Chills, Headache, Hyperhidrosis, Respiratory tract congestion
Clinical narrative: Severe chills Sweating Congestion Headache Eye strain
Age: 1.5
Sex: F
Vaccine: DTAPIPVHIB, HEPA, VARCEL
Symptoms: Rash
Clinical narrative: Pt experienced a rash
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19 pneumonia
Clinical narrative: Pfizer vaccine was administered outside of the clinic - reported by patient  ACUTE HYPOXEMIC RESPIRATORY FAILURE 9/3/2021 COVID-19 PNEUMONIA
Age: 76.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Fatigue, Headache, Lethargy, Malaise
Clinical narrative: My COVID-19 infection symptoms started on 03/14/2023 at 10:00. I had fever of 102.00, headache, lethargy,  nasal congestions and tiredness.  I took Sudafed, Zyrtec,  Claritin, and Mucinex  as night. I also took Tylenol for fever. I did a test that night using a home COVID-19 test which was positive. I called my doctor and  he prescribe me Lagevrio for 5 days .I had fever for 4 days. As of now I am more tired than before. I also had COVID-19 infection last year on June. I tested negative on 03/23/2023.
Age: 76.0
Sex: F
Vaccine: COVID19-2
Symptoms: Nasal congestion, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: My COVID-19 infection symptoms started on 03/14/2023 at 10:00. I had fever of 102.00, headache, lethargy,  nasal congestions and tiredness.  I took Sudafed, Zyrtec,  Claritin, and Mucinex  as night. I also took Tylenol for fever. I did a test that night using a home COVID-19 test which was positive. I called my doctor and  he prescribe me Lagevrio for 5 days .I had fever for 4 days. As of now I am more tired than before. I also had COVID-19 infection last year on June. I tested negative on 03/23/2023.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Product preparation issue
Clinical narrative: Menveo is a two-part vaccine. It has a powder in one vile that is to be reconstituted with a specific liquid from another vile. It was discovered by our vaccine coordinator that there was half of a dose left unused on three separate occasions. This was discovered in the late fall/early winter 2022. This means that there are three patients of our practice who received incomplete Menveo vaccines and we have not yet identified them. Presumably, the powder was reconstituted in a separate diluent.  We had IT run a report of all patients in a certain window of time who received Menveo at our practice. We compared it with our handwritten logs that clinical staff use to track all vaccines.  Unfortunately, the best we could do was to rule down the list to 8 potential patients. I did submit a separate report about one of these patients a few months ago as that was the first patient potentially identified   We have done lots of reeducation with clinical staff since this time. We have also implemented a protocol that all pediatric vaccines must be double checked by a second clinical staff person before being administered. Our vaccine coordinator is also taking a manual inventory weekly to ensure that should a mistake be made, we are aware of it closer to the date or error. We have also discussed with the medical director that for state supplied vaccines we are going to phase out the use of Menveo (two vial dose) and go back to using a (single vial dose.)  The course of action is to place a call to each of the 7 patients who got Menveo in the suspected time frame and explain that while we are not sure they are under vaccinated, it cannot hurt anything to repeat the Menveo vaccine. That would ensure they are fully vaccinated.   Our medical director and CDC rep has advised that a repeat dose is appropriate and should be offered to anyone affected. PCPs have been alerted and agree with the plan for office manager to reach out to patients/guardians
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, Septic shock, Urinary retention
Clinical narrative: HYPOXEMIA 7/8/2021 SEPTIC SHOCK  HYPOXEMIA 7/8/2021 URINARY RETENTION
Age: 16.0
Sex: F
Vaccine: MNQ
Symptoms: Product preparation issue, Single component of a two-component product administered
Clinical narrative: Menveo is a two-part vaccine. It has a powder in one vile that is to be reconstituted with a specific liquid from another vile. It was discovered by our vaccine coordinator that there was half of a dose left unused on three separate occasions. This was discovered in the late fall/early winter 2022. This means that there are three patients of our practice who received incomplete Menveo vaccines and we have not yet identified them. Presumably, the powder was reconstituted in a separate diluent.  We had IT run a report of all patients in a certain window of time who received Menveo at our practice. We compared it with our handwritten logs that clinical staff use to track all vaccines.  Unfortunately, the best we could do was to rule down the list to 8 potential patients. I did submit a separate report about one of these patients a few months ago as that was the first patient potentially identified   We have done lots of reeducation with clinical staff since this time. We have also implemented a protocol that all pediatric vaccines must be double checked by a second clinical staff person before being administered. Our vaccine coordinator is also taking a manual inventory weekly to ensure that should a mistake be made, we are aware of it closer to the date or error. We have also discussed with the medical director that for state supplied vaccines we are going to phase out the use of Menveo (two vial dose) and go back to using a (single vial dose.)  The course of action is to place a call to each of the 7 patients who got Menveo in the suspected time frame and explain that while we are not sure they are under vaccinated, it cannot hurt anything to repeat the Menveo vaccine. That would ensure they are fully vaccinated.      Our medical director has advised that a repeat dose is appropriate and should be offered to anyone affected. PCPs have been alerted and agree with the plan for office manager to reach out to patients/guardians
Age: 43.0
Sex: F
Vaccine: FLU4, HEPAB, TYP
Symptoms: Hypotonia, Tremor, Unresponsive to stimuli
Clinical narrative: When giving the flu shot in the left arm everything was fine, and when i gave the Typhim vaccine in the right arm everything was fine until I gave the 3rd vaccines the Twinrix in the right arm she went very limp and started to slide down the chair, she was nonresponsive and started to shake, I called for my pharmacist when she got there the patient was coming back to it. I asked her if she was okay, she was talking and answering all my questions. We gave her water and put a cold rag on the back of her neck.  Had her stay seated for about 15 mins she said she felt better i checked her heart rate and it was at 79 which she said was normal for her. i called her about and hour after and she said she was feeling okay. she stated she never had a reaction to any vaccines before.
Age: 61.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Blood creatine phosphokinase normal, Differential white blood cell count normal, Echocardiogram abnormal, Electrocardiogram ambulatory abnormal, Electrocardiogram normal
Clinical narrative: In early March I started being awoken by a raising heartbeat at night. It was for no reason whatsoever. I happened to be going to my annua l checkup and told him about and he put me on a Holter monitor. He also ran an EKG and thyroid test and those came back normal. On the 24th I felt like my heart was racing all day. Before the results came back. The next morning, I went to the emergency room. My temperature was normal.   My blood pressure was 127/81, mu oxygen was 100. While I was there, I was told by the doctors that my heart was going from 60 to 100 beats per minute and there was no indication as to why. They gave me Propranolol 40mg twice a day.  The Holter monitor results showed slight abnormalities. I went to the cardiologist on the 29th and he ordered an echocardiogram which was not remarkable. I followed with my general practitioner just yesterday. My emergency room reason for visit was tachycardia and heart palpitations.  I am now on beta blockers; I have not recovered from it.
Age: 61.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Full blood count normal, Heart rate increased, Metabolic function test normal, Palpitations, Tachycardia
Clinical narrative: In early March I started being awoken by a raising heartbeat at night. It was for no reason whatsoever. I happened to be going to my annua l checkup and told him about and he put me on a Holter monitor. He also ran an EKG and thyroid test and those came back normal. On the 24th I felt like my heart was racing all day. Before the results came back. The next morning, I went to the emergency room. My temperature was normal.   My blood pressure was 127/81, mu oxygen was 100. While I was there, I was told by the doctors that my heart was going from 60 to 100 beats per minute and there was no indication as to why. They gave me Propranolol 40mg twice a day.  The Holter monitor results showed slight abnormalities. I went to the cardiologist on the 29th and he ordered an echocardiogram which was not remarkable. I followed with my general practitioner just yesterday. My emergency room reason for visit was tachycardia and heart palpitations.  I am now on beta blockers; I have not recovered from it.
Age: 61.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Thyroid function test normal, X-ray normal
Clinical narrative: In early March I started being awoken by a raising heartbeat at night. It was for no reason whatsoever. I happened to be going to my annua l checkup and told him about and he put me on a Holter monitor. He also ran an EKG and thyroid test and those came back normal. On the 24th I felt like my heart was racing all day. Before the results came back. The next morning, I went to the emergency room. My temperature was normal.   My blood pressure was 127/81, mu oxygen was 100. While I was there, I was told by the doctors that my heart was going from 60 to 100 beats per minute and there was no indication as to why. They gave me Propranolol 40mg twice a day.  The Holter monitor results showed slight abnormalities. I went to the cardiologist on the 29th and he ordered an echocardiogram which was not remarkable. I followed with my general practitioner just yesterday. My emergency room reason for visit was tachycardia and heart palpitations.  I am now on beta blockers; I have not recovered from it.
Age: 12.0
Sex: F
Vaccine: MNQ
Symptoms: Product preparation issue, Single component of a two-component product administered
Clinical narrative: Menveo is a two-part vaccine. It has a powder in one vile that is to be reconstituted with a specific liquid from another vile. It was discovered by our vaccine coordinator that there was half of a dose left unused on three separate occasions. This was discovered in the late fall/early winter 2022. This means that there are three patients of our practice who received incomplete Menveo vaccines and we have not yet identified them. Presumably, the powder was reconstituted in a separate diluent.  We had IT run a report of all patients in a certain window of time who received Menveo at our practice. We compared it with our handwritten logs that clinical staff use to track all vaccines.  Unfortunately, the best we could do was to rule down the list to 8 potential patients. I did submit a separate report about one of these patients a few months ago as that was the first patient potentially identified   We have done lots of reeducation with clinical staff since this time. We have also implemented a protocol that all pediatric vaccines must be double checked by a second clinical staff person before being administered. Our vaccine coordinator is also taking a manual inventory weekly to ensure that should a mistake be made, we are aware of it closer to the date or error. We have also discussed with the medical director that for state supplied vaccines we are going to phase out the use of Menveo (two vial dose) and go back to using a (single vial dose.)  The course of action is to place a call to each of the 7 patients who got Menveo in the suspected time frame and explain that while we are not sure they are under vaccinated, it cannot hurt anything to repeat the Menveo vaccine. That would ensure they are fully vaccinated.      Our medical director has advised that a repeat dose is appropriate and should be offered to anyone affected. PCPs have been alerted and agree with the plan for office manager to reach out to patients/guardians
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Coagulopathy, Pulmonary embolism
Clinical narrative: Pfizer vaccine was administered outside of the clinic - reported by patient   COAGULOPATHY, UNSPECIFIED TYPE 1/26/2022 BACK PAIN  COAGULOPATHY, UNSPECIFIED TYPE 1/26/2022 ACUTE PULMONARY EMBOLISM
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: given bivalent instead of primary series of monovalent
Age: 63.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Discharge, Dysphonia, Feeling cold, Headache
Clinical narrative: I was diagnosed with Covid 19 on November 14, 2022. I experienced headache, severe sore throat, drainage, hoarse, coldness, I was taking a cough suppressant and cough drops for my symptoms. I was also prescribed codeine cough syrup with a TRELEGY steroid inhaler.
Age: 63.0
Sex: F
Vaccine: COVID19-2
Symptoms: Oropharyngeal pain, SARS-CoV-2 test
Clinical narrative: I was diagnosed with Covid 19 on November 14, 2022. I experienced headache, severe sore throat, drainage, hoarse, coldness, I was taking a cough suppressant and cough drops for my symptoms. I was also prescribed codeine cough syrup with a TRELEGY steroid inhaler.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Benign prostatic hyperplasia, Respiratory failure
Clinical narrative: ACUTE RESPIRATORY FAILURE 8/27/2022 ACUTE RESPIRATORY FAILURE  ACUTE HYPOXEMIC RESPIRATORY FAILURE 8/30/2022 ACUTE RESPIRATORY FAILURE  RESPIRATORY FAILURE, UNSPECIFIED ACUITY 9/8/2022 ACUTE RESPIRATORY FAILURE  ACUTE RESPIRATORY FAILURE 8/27/2022 BPH (BENIGN PROSTATIC HYPERPLASIA)  ACUTE HYPOXEMIC RESPIRATORY FAILURE 8/30/2022 BPH (BENIGN PROSTATIC HYPERPLASIA)  RESPIRATORY FAILURE, UNSPECIFIED ACUITY 9/8/2022 BPH (BENIGN PROSTATIC HYPERPLASIA)